IA
XBIT icon

IFP Advisors’s XBiotech XBIT Stock Holding History

IFP Advisors’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2
Closed -$8 – 4665
2024
Q4 		$8 Buy
+2
New +$14 ﹤0.01% 4545
2023
Q1 		– Sell
-200
Closed -$1K – 4457
2022
Q4 		$1K Hold
200
– – ﹤0.01% 4518
2022
Q3 		$1K Hold
200
– – ﹤0.01% 4707
2022
Q2 		$1K Hold
200
– – ﹤0.01% 4476
2022
Q1 		$1K Sell
200
-500
-71% -$5.02K ﹤0.01% 4474
2021
Q4 		$8K Hold
700
– – ﹤0.01% 2320
2021
Q3 		$9K Hold
700
– – ﹤0.01% 2339
2021
Q2 		$11K Hold
700
– – ﹤0.01% 2183
2021
Q1 		$12K Hold
700
– – ﹤0.01% 2074
2020
Q4 		$11K Hold
700
– – ﹤0.01% 2052
2020
Q3 		$14K Buy
700
+100
+17% +$1.73K ﹤0.01% 1791
2020
Q2 		$8K Buy
+600
New +$8.43K ﹤0.01% 1918

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

IFP Advisors's XBIT Position: Q1 2025 in Review

IFP Advisors sold out of XBiotech (XBIT) in Q1 2025, closing a stake of 2 shares — an estimated $8 sold.

IFP Advisors first reported a position in XBIT in Q2 2020 and held it in 12 quarters. The position peaked at $14K in Q3 2020. 55 funds tracked by Wall St. Rank hold XBIT as of Q1 2025.

  • IFP Advisors reported no remaining XBiotech position as of Q1 2025 after selling out during the quarter.
  • IFP Advisors sold 2 XBiotech shares in Q1 2025, an estimated $8.
  • IFP Advisors first reported a position in XBiotech in Q2 2020 and held it in 12 quarters.
  • IFP Advisors's XBiotech position peaked at $14K in Q3 2020.
  • 55 funds tracked by Wall St. Rank held XBiotech as of Q1 2025.

Based on IFP Advisors's 13F filing for Q1 2025, filed 5 May 2025.